Mice lacking the BEST2 gene have altered aqueous humor flow and decreased intraocular pressure (IOP), suggesting Best2 may be a potential pharmaceutical target for lowering IOP (e.g., in the treatment of glaucoma) [49,50]. The gene discussed is BEST2; the disease is glaucoma.